K212216: Prismaflex ST60 Set, Prismaflex ST100 Set, Prismaflex ST150 set (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K212216 (Prismaflex ST60 Set, Prismaflex ST100 Set, Prismaflex ST150 set, cleared 2022-04-01 for Baxter Healthcare Corporation) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K212216
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK212216
Cleared Device Trade / Generic NamePrismaflex ST60 Set, Prismaflex ST100 Set, Prismaflex ST150 set
FDA Applicant on FilingBaxter Healthcare Corporation
FDA 3-Letter Product ClassificationProduct Code KDI
FDA Substantial Equivalence Decision Date2022-04-01
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Baxter International across sibling Meru public-data platforms.

Inspect consolidated manufacturer lineage at Baxter Healthcare Corporation, compare peer devices under FDA Product Code KDI, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.